EP4295839A1 — Combination of valsartan and indapamide

USPTO Abstract

The invention relates to an oral pharmaceutical dosage form, preferably a bilayer tablet comprising a first layer and a second layer, wherein the pharmaceutical dosage form comprises (i) valsartan or a physiologically acceptable salt thereof; preferably wherein the pharmaceutical dosage form provides conventional release of valsartan or the physiologically acceptable salt thereof; and (ii) indapamide or a physiologically acceptable salt thereof; preferably wherein the pharmaceutical dosage form provides modified release of indapamide or the physiologically acceptable salt thereof. The invention further relates to a process for preparing such pharmaceutical dosage form.